Identification of atypical PML-RARA breakpoint in a patient with acute promyelocytic leukemia

Said Ismail1, Nidaa Ababneh, Abdalla Awidi

  • 1Faculty of Medicine, University of Jordan, Amman, Jordan. sismail@ju.edu.jo

Acta Haematologica
|October 16, 2007
PubMed

Insights

This study details a rare atypical breakpoint in Acute Promyelocytic Leukemia (APL), a subtype of M3 leukemia. Sequencing confirmed the unusual PML-RARA fusion transcript, highlighting the importance of molecular analysis in APL diagnosis.

Area of Science:

  • Hematology
  • Molecular Biology
  • Genetics

Background:

  • Acute Promyelocytic Leukemia (APL) is characterized by the t(15;17) translocation, forming the PML-RARA fusion gene.
  • Three main PML-RARA fusion transcripts (bcr1, bcr2, bcr3) arise from different breakpoint locations within the PML gene.

Observation:

  • A rare atypical bcr2 breakpoint within exon 6 of the PML gene was identified in a patient with APL.
  • Fluorescent in situ hybridization confirmed the t(15;17) translocation.
  • Reverse transcription polymerase chain reaction revealed atypical band sizes compared to classical breakpoints.

Findings:

  • Sequence analysis definitively confirmed an atypical bcr2 transcript.
  • The patient presented with morphological, cytogenetic, and molecular features consistent with APL.
  • The patient achieved complete remission following treatment.

Implications:

  • This case underscores the necessity of sequencing unusual PCR products to confirm transcript identity in APL.
  • Further research with similar cases is required to determine the prognostic significance of this rare transcript.
  • Accurate molecular characterization is crucial for understanding APL heterogeneity and guiding treatment.

Related Concept Videos